
Male Birth Control Startup Gets $7 Million
Business Wars Daily
00:00
Adam: A Non-Hormonal Reversible Birth Control for Men
David Brown: For decades, the dominant narrative around birth control has been that it's for women. He says a Virginia-based pharma company is turning their focus to birth control for men and those who've been assigned male at birth. Contraline just wrapped up a $7 million funding round with its new non-hormonal reversible birth control product called Adam. The gel immediately blocks the flow of sperm, but over time it disintegrates, which makes it temporary.
Transcript
Play full episode